CombinatoRx, Incorporated
CombinatoRx Reports Financial Results for the Fourth Quarter and Year End 2008
Published in Cancer Weekly, March 17th, 2009
“We recently restructured CombinatoRx to focus on our core strengths; identifying novel product candidates based on synergy and selectivity,” commented Alexis Borisy, President and CEO of CombinatoRx. “While we had setbacks in 2008, we should not overlook the accomplishments which provide evidence of the fundamental value of the CombinatoRx approach”. 2008 and Recent Accomplishments Provided important clinical translational evidence for our dissociated glucocorticoid candidate, Synavive (CRx-102), with the results from COMET-1 (CRx-102...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-03-17)
More Articles from Cancer Weekly
- Allos Therapeutics, Inc.
Allos Therapeutics Reports 2008 Results - American Academy of Periodontolgy
Go Green for Healthy Teeth and Gums - Breast Cancer
Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Breast Cancer in Newly Diagnosed Breast Cancer Patients - Cancer Gene Therapy
Researchers at National Institutes of Health have published new data on cancer gene therapy - Cancer Vaccines
New cancer vaccines study findings have been published by X.X. Song and colleagues - Cancer Vaccines
Reports from Hebrew University highlight recent research in cancer vaccines - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
